Angiodynamics (ANGO) Acquisitions (2012 - 2024)

Angiodynamics (ANGO) posted Acquisitions of $3.2 million for Q1 2024, up 501.85% on a QoQ basis from $540000.0 in Q4 2022.

Angiodynamics (ANGO) Acquisitions (2012 - 2024) Analysis & Trends

Angiodynamics' Acquisitions history runs 11 years deep, the most recent figure standing at $3.2 million for Q1 2024.

Quarterly Acquisitions changed N/A year-over-year to $3.2 million in Q1 2024, while the trailing twelve-month figure through Feb 2024 was $3.8 million (up 601.85% YoY) and the FY2012 annual result came in at $237.9 million, up 21803.04% from the prior year.
Acquisitions was $3.2 million for Q1 2024 at Angiodynamics, up from $540000.0 in the prior quarter.
Across five years, Acquisitions topped out at $10.0 million in Q1 2020 and bottomed at $540000.0 in Q4 2022.
A 4-year average of $4.3 million and a median of $3.4 million in 2021 frame the typical range for Acquisitions.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	24.88 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	18.96 Mn
10	Angiodynamics	558.11 Mn	504.25 Mn	46.77 Mn	-

Download Data